Daiichi Sankyo Group is a global leader in the pharmaceutical industry with over 125 years of innovation and scientific expertise. Committed to improving healthcare standards, the company focuses on developing and supplying innovative therapies to meet diverse medical needs worldwide. With a presence in more than 20 countries and a workforce of 18,000 employees, Daiichi Sankyo is particularly dedicated to oncology and other critical research areas, including rare diseases and immune disorders. The company fosters a collaborative and inclusive work environment, emphasizing individual contributions and providing employees with the necessary tools and training to excel in their roles.